NASDAQ:BDSX - Nasdaq - US09075X1081 - Common Stock - Currency: USD
BDSX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. BDSX may be in some trouble as it scores bad on both profitability and health. BDSX shows excellent growth, but is valued quite expensive already.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -44.15% | ||
ROE | -205.65% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 78.17% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.74 | ||
Debt/FCF | N/A | ||
Altman-Z | -6.17 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.76 | ||
Quick Ratio | 2.76 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:BDSX (5/2/2025, 3:40:48 PM)
0.5245
-0.01 (-1.04%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.07 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 3.67 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -44.15% | ||
ROE | -205.65% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 78.17% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.74 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 59.59% | ||
Cap/Sales | 4.82% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 2.76 | ||
Quick Ratio | 2.76 | ||
Altman-Z | -6.17 |